Compare CLVS

The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Wednesday's prices. Each symbol is a hyperlink or shortcut to more information.

CLVS 19.74%

CLVS $6.55 1.08 (19.74%)
Clovis Oncology Inc
Profile NASDAQ: CLVS $320 Million Small-Cap. Show More

CLVS Profile

Market Cap 320 Million
CLVS Description

Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, the EU, and additional international markets. The firm target its development programs for the treatment of specific subsets of cancer populations. Its product candidates include Rucaparib and Lucitanib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer whereas Lucitanib includes Rucaparib Combo and Nivolumab Combo.

Visit Website

CLVS Earnings

EPS -1.72 P/E Ratio --
Previous Thu, Aug 1, 2019
Latest Tue, Oct 29, 2019 (15 days ago) Price +65.82%

CLVS Dividend

Yield --
Ex-Date --
Pay Date --
History --

CLVS Charts

52 Week Low $2.93 on Mon, Oct 28, 2019.
1 Year
Oct 28, 2019
Feb 28, 2019

Symbol Price Day Ξ” YTD Ξ”
CLVS $6.55 19.74% -66.22%


Symbol Surfing

How can we make Symbol Surfing better?


©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy